Hypofractionated helical intensity-modulated radiotherapy of the prostate bed after prostatectomy with or without the pelvic lymph nodes - the PRIAMOS trial

While evidence on safety and efficacy of primary hypofractionated radiotherapy in prostate cancer is accumulating, data on postoperative hypofractionated treatment of the prostate bed and of the pelvic lymph nodes is still scarce. This phase II trial was initiated to investigate safety and feasibili...

Full description

Saved in:
Bibliographic Details
Main Authors: Krause, Sonja (Author) , Sterzing, Florian (Author) , Neuhof, Dirk (Author) , Edler, Lutz (Author) , Debus, Jürgen (Author) , Herfarth, Klaus (Author)
Format: Article (Journal)
Language:English
Published: 31 October 2012
In: BMC cancer
Year: 2012, Volume: 12
ISSN:1471-2407
DOI:10.1186/1471-2407-12-504
Online Access:Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1186/1471-2407-12-504
Verlag, kostenfrei, Volltext: https://doi.org/10.1186/1471-2407-12-504
Get full text
Author Notes:Sonja Krause, Florian Sterzing, Dirk Neuhof, Lutz Edler, Juergen Debus and Klaus Herfarth
Description
Summary:While evidence on safety and efficacy of primary hypofractionated radiotherapy in prostate cancer is accumulating, data on postoperative hypofractionated treatment of the prostate bed and of the pelvic lymph nodes is still scarce. This phase II trial was initiated to investigate safety and feasibility of hypofractionated treatment of the prostate bed alone or with the pelvic lymph nodes.
Item Description:Gesehen am 15.11.2018
Physical Description:Online Resource
ISSN:1471-2407
DOI:10.1186/1471-2407-12-504